Results 181 to 188 of about 50,528 (188)

Precursor behavior and functional analysis: A brief review

Journal of Applied Behavior Analysis, 2019
exaly  

Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 28/06/2017, Revision: 4, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Lineage alteration in precursor B cell acute lymphoblastic leukemia following T cell lymphoblastic lymphoma.

, 1992
Gemma Nw, Lovell Ma, Bringelsen Ka, Williams Me   +3 more
openalex  

Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 28/06/2017, Revision: 3, Status: Authorised

Case Medical Research, 2018
openaire   +1 more source

Human medicines European public assessment report (EPAR): Jylamvo, methotrexate, Arthritis, Psoriatic,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Psoriasis,Arthritis, Rheumatoid,Arthritis, Date of authorisation: 29/03/2017, Revision: 4, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Jylamvo, methotrexate, Arthritis, Psoriatic,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Psoriasis,Arthritis, Rheumatoid,Arthritis, Date of authorisation: 29/03/2017, Revision: 2, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Imatinib Actavis, imatinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Myelodysplastic-Myeloproliferative Diseases,Hypereosinophilic Syndrome,Dermatofibrosarcoma, Date of authorisation: 17/04/2013, Revision: 12, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Imatinib Teva, imatinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Myelodysplastic-Myeloproliferative Diseases,Hypereosinophilic Syndrome,Dermatofibrosarcoma, Date of authorisation: 07/01/2013, Revision: 13, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source